We always love to see our own Martin Borch Jensen in action. Thank you David Eagleman

To end the year: breakdown and advice for ARPA-H's healthspan-focused PROSPR call, largely from discussions in @norngroup. The call is very ambitious, a sincere attempt at overcoming several of the biggest barriers for longevity medicine.

On January 28, 2025, we’re kicking off Nucleate: Inside Aging with a free virtual opening session featuring two pioneering leaders in aging biology and longevity biotech. Register here: lu.ma/ej49cnxn Martin Borch Jensen, @EricVerdin, Buck Institute, Gordian Biotechnology, Norn Group

@Gordian needs your help to cure age-related disease! Pooled in vivo screening gives a lot of targets with efficacy for age-related disease. Next: confirm human translation w patient samples, and we can't keep up! So we're #hiring two roles: both hands-on w complex ex vivo

Moira Gunn from BioTech Nation (Moira Gunn) hosted a very interesting and insightful interview talking about Reprogramming the Future with Martin Borch Jensen and Francisco LePort from Gordian Biotechnology (Gordian Biotechnology) biotechnation.com/episodes/repro…

This news should instill urgency and remind us to ask ‘why not sooner?’. Martin Borch Jensen shared a long-term vision for how cures could become abundant, if we believe fast, systematic cure discovery is possible, and build the tools to make it happen. gordian.bio/blog/cures-on-…

Our CEO discussed the latest developments at Gordian with Danny Sullivan, including partnering efforts, cures for OA, and vision for the future.